Graydon Harker

2.2k citations
15 papers · 1.2k indexed · h-index 11

Impact in

  • Oncology top 5%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Pancreatic and Hepatic Oncology Research
    • Neutropenia and Cancer Infections
  • Surgery top 10%
    • Nausea and vomiting management
    • Anesthesia and Pain Management

Papers in

    • Cancer Treatment and Pharmacology 6
    • HER2/EGFR in Cancer Research 3
    • Colorectal Cancer Treatments and Studies 3
    • Bone health and treatments 2

Graydon Harker

15 papers receiving 1.1k citations

Peers

Graydon Harker
Comparison fields: 5 of 80
  • Oncology 647
  • Surgery 509
  • Cancer Research 129
  • Hepatology 68
  • Physiology 200
Replace Stefan Madajewicz with:
Stefan Madajewicz United States
Julio Hajdenberg United States
James Raschko United States
Jeng‐Kae Jiang Taiwan
K. Buser Switzerland
Drew K. Seisler United States
R. de las Peñas Spain
Emiliano Tamburini Italy
Céline Lepère France
Ian D. Schnadig United States
Graydon Harker relative to Stefan Madajewicz United States Stefan Madajewicz's profile →
Citations per field
00.5×1.5×2.4×
Stefan Madajewicz · 1×
Citations per year

Countries citing papers authored by Graydon Harker

Since Specialization
Citations

This map shows the geographic impact of Graydon Harker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graydon Harker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graydon Harker more than expected).

Fields of papers citing papers by Graydon Harker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graydon Harker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graydon Harker. The network helps show where Graydon Harker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Graydon Harker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Graydon Harker Line = papers co-authored together Graydon Harker links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 201218
2 20127
3 201158
4 201116
5 20092
6 200949
7 20084
8 200611
9 2006227
10 2003224
11 1997402
12 1991121
13 19902
14 198917
15 198713

About Graydon Harker

Graydon Harker is a scholar working on Otorhinolaryngology, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (3 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Nausea and vomiting management (2 papers), Bone health and treatments (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Oncology (647 citations), Surgery (509 citations), Cancer Research (129 citations), Hepatology (68 citations) and Physiology (200 citations). Graydon Harker has collaborated with scholars based in United States. Frequent co-authors include David R. Gandara, Paul J. Hesketh, Thomas Beck, Celeste Lindley, John D. Hainsworth, Mark G. Kris, Steven M. Grunberg, Matti Aapro, M. R. Moore and Luis Villa. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Lung Cancer, Cancer Research and Otolaryngology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026